.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Deloitte
Harvard Business School
Farmers Insurance
AstraZeneca
Chinese Patent Office
Express Scripts
Accenture
McKinsey
Johnson and Johnson

Generated: September 20, 2017

DrugPatentWatch Database Preview

TRIMETH/SULFA Drug Profile

« Back to Dashboard

Which patents cover Trimeth/sulfa, and when can generic versions of Trimeth/sulfa launch?

Trimeth/sulfa is a drug marketed by Alpharma Us Pharms and Naska and is included in three NDAs.

The generic ingredient in TRIMETH/SULFA is sulfamethoxazole; trimethoprim. There are twenty-six drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.

Summary for Tradename: TRIMETH/SULFA

Patents:0
Applicants:2
NDAs:3
Bulk Api Vendors: see list95
Clinical Trials: see list20
Patent Applications: see list94
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TRIMETH/SULFA at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms
TRIMETH/SULFA
sulfamethoxazole; trimethoprim
SUSPENSION;ORAL072289-001May 23, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Alpharma Us Pharms
TRIMETH/SULFA
sulfamethoxazole; trimethoprim
SUSPENSION;ORAL072398-001May 23, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Naska
TRIMETH/SULFA
sulfamethoxazole; trimethoprim
SUSPENSION;ORAL072399-001May 23, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
UBS
Medtronic
Novartis
Argus Health
QuintilesIMS
Merck
Covington
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot